Донсков С.И., Мороков В.А. Группы крови человека. Руководство по иммуносерологии

74.Умнова М.А., Пискунова Т.М., Ичаловская Т.А. (Umnova M. A., Piskunova T. M., Ichalovskaya T.A.) Isosensitization to Kell, Cellano and Duffy Factors and the Distribution of theseFactorsamongthePopulation//Proc.9-thCongr.Int.Soc.BloodTransf.–Mexico,1962.– Karger.–1964.–Р.344–346.

75.Умнова М.А., Пискунова Т.М., Ичаловская Т.А. Сенсибилизация беременной фактором Келл и распределение этого фактора // Акушерство и гинекология. – 1963. – № 5. – С. 79–82.

76.Умнова М.А., Прокоп О., Пискунова Т.М. и др. Распределение различных факторов крови у населения Москвы // XII Междунар. конгр. антропол. этнограф. наук. – М., 1964. – 8 с.

77.Умнова М.А., Хорват А. Распределение групповых факторов Rh-Hr, MNSs, K-k и P у населения Венгрии // Вопр. антропологии. – 1965. – Вып. 20.– С. 135–137.

78.Хромова Е.А. Иммуносерологические особенности крови аборигенов Среднего Приобья: автореф. дис. … канд. мед. наук. – Тюмень, 2003. – 22 с.

79.Червяков В.И. Профилактика посттрансфузионных осложнений, обусловленных антигенами Kell и hr' (c): автореф. дис. … канд. мед наук. – М., 2000. – 29 с.

80.Чимиддуламын Шарав. Групповые свойства крови у монголов: автореф. дис. … канд. мед наук. – 1970. – 16 с.

81.Шереметьева В.А., Горшков В.А. Коряки Камчатки. Генетическая характеристика и формирование генофонда // Генетика – 1977. – Т. 12. – С. 1119.

82.Эрикссон А., Золотарева И.М., Козинцев А.Г. и др. Генетические исследования марийцев (черемисов): Новые исследования по антропологии марийцев. – М., 1979. – С. 7.

83.Эрикссон А., Франтс Р. Исследование групп крови у коми-зырян в СССР // Финноугорский сборник. – М., 1982. – С. 79.

84.Abramson N., Schur P.H. The IgG subclasses of red cells antibodies and relationship to monocyte binding // Blood. – 1972. – V. 40. – Р. 500.

85.Advani H., Zamor J., Judd W. J. et al. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide // Brit. J. Haemat. – 1982. – V. 51. – Р. 107–115.

86.Allen F.H., Krabbe S.M.R., Corcoran P.A. A new phenotype (McLeod) in the Kell bloodgroup system // Vox Sang. – 1961. – V. 6. – Р. 555–560.

87.Allen F.H., Lewis S.J. Kp a (Penney), a new antigen in the Kell blood group system // Vox Sang. – 1957. – V. 2. – Р. 81–87.

88.Allen F.H., Lewis S.J., Fudenburg H. Studies of anti-Kp b, a new antibody in the Kell blood group system // Vox Sang. – 1958. – V. 3. – Р. 1–13.

89.Allen F.H., Rosenfield R.E. Notation for the Kell blood-group system // Transfusion. – 1961. – V. 1. – Р. 305–307.

90.Allen F.H., Warshaw A.L. Blood group sensitization. A comparison of antigens K1 (Kell) and c (hr') // Vox Sang. – 1962. – V. 7. – Р. 222.

91.Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress // Ann. Rev. Neurosci. – 1993. – V. 16. – Р. 73–93.

92.Anderson R.R., Sosler S.D., Kovach J., DeChristopher P.J. Delayed hemolytic transfusion reaction due to anti-Js a in an alloimmunized patient with a sickle cell syndrome //Amer. J. Clin. Path. – 1997. – V. 108. – Р. 658–661.

93.Archer G.T., Cooke B.R., Mitchell K., Parry P. Hyper-immunisation des donneurs de sang pour la production def gamma-globulines anti-Rh(D) // Rev. Franc. Transfus. – 1969. – V. 12. – Р. 341.

94.Avent N.D., Martin P.G. Kell typing by allele-specific PCR (ASP) // Brit. J. Haemat. – 1996 – V. 93. – Р. 728–730.

95.Ballas S.K., Bator S.M., Aubuchon J.P. et al. Abnormal membrane physical properties of red cells in McLeod syndrome // Transfusion. – 1990. – V. 30. – Р. 722–727.

431

96.Bar Shany S., Ben Porath D., Levene C. et al. K22, a ‘new’ para-Kell antigen of high frequency // Vox Sang. – 1982. – V. 42. – Р. 87–90.

97.Barrasso C, Baldwin M.L., Drew H., Ness P.M. In vivo survival of K:18 red cells in a recipient withanti-K18//Transfusion.–1983.–V.23.–Р.258–259.

98.Barrasso C., Eska P., Grindon A.J. et al.Anti-k18: an antibody defining another highfrequency antigen related to the Kell blood group system // Vox Sang. – 1975. –

V.29. – Р. 124–127.

99.Beanie K.M., Heinz B., Korol S.et al.Anti-K12 in the serum of two brothers: inheritance of the K:–12phenotype//Rev.Franc.Transfus.Immunohemat.–1982.–V.25.–Р.611–618.

100.Beattie K.M., Shafer A.W., Sigmund K., Cisco S. Mass screening ofAmerican Black donors toidentifyhighincidenceantigen-negativebloods[Abstract]//19-thCongr.Int.Soc.Blood Transfus., 1986. – Р. 312.

101.Beck M.L., Marsh W.L., Pierce S.R. et al. Auto-anti-Kp b associated with weakened antigenicity in the Kell blood group system: a second example // Transfusion. – 1979. –

V.19. – Р. 197–202.

102.Belhacene N., Maulon L., Guerin S. et al. Differential expression of the Kell blood group and CD 10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin // FASEB J. – 1998. – V. 12. – Р. 531–539.

103.Bertelson C.J., Pogo A.O., Chaudhuri A. et al. Localization of the McLeod locus (XK) within Xp21 by deletion analysis //Amer. J. Hum. Genet. – 1988. – V. 42. – Р. 703–711.

104.Blancher A., Reid M.E., Socha W.W. Cross-reactivity of antibodies to human and primate red cell antigens // Transfus. Med. Rev. – 2000. – V. 14. – Р. 161–179.

105.Bony V., Gane P., Bailly P., Cartron J.P. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation // Brit. J. Haemat. – 1999. –

V.107. – Р. 263–274.

106.Bove J.R., Johnson M., Francis B.J. et al.Anti-K w defining a new antigenic determinant // ProgramAABB 18thAnn. Meeting. – Florida, 1965. – Р. 60.

107.Bowman J.M., Harman F.A., Manning C.R., Pollock J.M. Erythroblastosis fetalis produced by anti-k // Vox Sang. – 1989. – V. 56. – Р. 187–189 and Vox Sang. – 1990. –

V.58. – Р. 139.

108.Branch D. R., Gaidulis L., Lazar G. S. Human granulocytes lack red cell Kx antigen // Brit.

J.Haemat. – 1986. – V.62. – Р. 747–755.

109.BranchD.R.,MuenschH.A.,SySiokHanA.L.,PetzL.D.Disulfidebondsarearequirement for Kell and Cartwright (Yt a) blood group antigen integrity // Brit. J. Haemat. – 1983. –

V.54. – Р. 573–578

110.Branch D.R., Petz L.D. A new reagent (ZZAP) having multiple applications in immunohematology //Amer. J. Clin. Path. – 1982. – V. 7. – Р. 161–167.

111.Branch D.R., Sy Siok Han A.L., Petz L.D. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells // Brit. J. Haemat. – 1985 – V. 59 – Р. 505–512.

112.Brendel W.L., Issitt P.D., Moore R.E. et al. Temporary reduction of red cell Kell system antigen expression and transient production of anti-Kp b in surgical patient // Biotest Bull. – 1985. – V. 2. – Р. 201–206.

113.Brown A., Berger R., Lasko D. et al. The Day phenotype: a ‚new‘ variant in the Kell blood group system // Rev. Franc. Transfus. Immunohemat. – 1982. – V. 25 – Р. 619–627.

114.Brzica S.M., Rhodes K.H., Pineda A.A., Taswell H.E. Chronic granulomatous disease and the McLeod phenotype: successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction // Mayo Clin. Proc. – 1977. –

V.52. – P. –153.

115.Byrne P.C., Deck M., Qyen R. et al. Serological and biochemical studies on a previously undescribed Kmod individual [Abstract] // Transfusion. – 1993. – V. 33 (Suppl.). – Р. 55S.

432

116.Caine M.E., Mueller-Heubach E. Kell sensitization in pregnancy // Amer. J. Obstet. Gynec. – 1986. – V. 154. – Р. 85–90.

117.Callender S., Race R.R. A serological and genetical study of multiple antibodies formed in response to blood transfusion by a patient with lupus erythematosus diffuses // Ann. Eugen. – 1946. – V. 13. – Р. 102–117.

118.Callender S., Race R.R., Paykoc Z.V. Hypersensitivity to transfused blood // Brit. Med.

J.– 1945. – ii. – Р. 83.

119.Camara-Clayette V., Rahuel C., Lopez C. et al. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells // Biochem. J. – 2001. – V. 356. – Р. 171–180.

120.CarbonnetF.,HattabC.,CallebautI.etal.Kx,aquantitativelyminorproteinfromhuman erythrocytes, is palmitoylated in vivo // Biochem. Biophys. Res. Commun. – 1998. –

V.250. – Р. 569–574.

121.Carbonnet F., Hattab C., Cartron J. P., Bertrand O. Kell and Kx, two disulphide-linked proteins of the human erythrocyte membrane are phosphorylated in vivo // Biochem. Biophys. Res. Commun. – 1998. – V. 247. – Р. 569–575.

122.Carbonnet F., Hattab C., Collec E. et al. Immunochemi-cal analysis of the Kx protein from humanredcellsofdifferentKellphenotypesusingantibodiesraisedagainstsyntheticpeptides// Brit.J.Haemat.–1997.–V. 96.– Р. 857–863.

123.CarstairsK.,RuthledgeHardingS.,LueK.etal.Anti-K9inanuntransfusedMcLeodindividual [Abstract]//Transfusion.–1988.–V. 28(Suppl.).–Р. 20S.

124.ChesterM.A.,JohnsonU.,LundbladA.etal.Proceedingsofthe2-ndInternationalWorkshop on MonoclonalAntibodiesAgainst Human Red Blood Cell and RelatedAntigens., 1990. –

P.126–138.

125.Chown B., Lewis M., Kaita H. A ‘new’ Kell blood-group phenotype // Nature. – Lond., 1957. – V. 180. – Р. 711.

126.ChownB.,LewisM.,KaitaH.etal.Thepedigreesoftwopeoplealreadyreportedasofphenotype K −,k −,Kp(a −b −)//VoxSang.–1961.–V. 6.– Р. 620–623.

127.Chown B., Lewis M., Kaita H., Philipps S. Some blood group frequencies in a Caucasian population//VoxSang.–1963.–V. 8.– Р. 378–381.

128.Chu T.H., Yazdanbakhsh K., Qyen R. et al. Production and characterization of anti-Kell, monoclonal antibodies using transfected cells, as the immunogen // Brit. J. Haemat. – 1999. – V. 106. – Р. 817–823.

129.Claperon A., Rose C., Gane P. et al. . The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein // J. Biol. Chem. – 2005. – V. 280. – N 22. – Р. 21272–21283.

130.Clark A., Monaghan W.P., Martin C.A. Two additional examples of non-transfusion-stimulated anti-Kell//Amer.J.Med.Tech.–1981.–V. 47.–Р. 983–984.

131.CollecE.,ColinY.,CarbonnetF.etal.Structureandexpressionofthemousehomologueofthe XKgene//Immunogenetics.–1999.–V. 50.–Р. 16–21.

132.CoombsR.R.,MourantA.E.,RaceR.R.Detectionofweakand«incomplete»Rhagglutinins: a new test // Lancet. – 1945. – V. 2. – Р. 15.

133.Coombs R.R., Mourant A.E., Race R.R. In-vivo isosensitization of red cells in babies with haemolytic disease // Lancet. – 1946. – i. – Р. 264–266.

134.Corcoran P.A., Allen F.H., Lewis M., Chown B.Anew antibody, anti-Ku (anti-Peltz), in the Kell blood group system // Transfusion. – 1961. – V. 1. – Р. 181–183.

135.Costamagna L., Barbarini M., Viarengo G.L. et al. A case of hemolytic disease of the newborn due to anti-Kp a // Immunohematology. – 1997. – V. 13. – Р. 61–62.

136.CroucherB.E.Differentialdiagnosisofdelayedtransfusionreaction//AABB:Aseminaron laboratory management of hemolysis., 1979.

433

137.CurnutteJ.,BemillerL.ChronicgranulomatousdiseasewithMcLeodphenotype:anuncommon occurrence[Abstract]//Transfusion.–1995. – V. 35(Suppl.).– Р. 60S.

138.Dacus J.V., Spinnato J.A. Severe erythroblastosis fetalis secondary to anti-Kp b sensitization // Amer.J.Obstet.Gynec.–1984. – V. 150.–Р. 888–889.

139.DanekA.,RubioJ.P.,RampoldiL.etal.McLeodneuroacanthocytosis:genotypeandphenotype

//Ann.Neurol.–2001. – V. 50.–Р. 755–764.

140.Daniels G.L. Blood group antigens of high frequency: a serological and genetical study: PhD thesis.–UniversityofLondon,1980.

141.DanielsG.L.KellandKxbloodgroupsystems:HumanBloodGroups.–2-nded.–Oxford: Blackwell Science, 2002. – Р. 295–323.

142.DanielsG.L.Kellrelatedantibodies//RevFrancTransfusImmunohemat.–1988.–V.31.– Р. 395–405.

143.Daniels G.L., Anstee D.J., Cartron J.P. et al. Terminology for red cell surface antigens – Makuhari report // Vox Sang. – 1996. – V. 71. – Р. 246–248.

144.Daniels G.L., ed. Third International Workshop on Monoclonal Antibodies Against Human Red Blood Cell and Related Antigens // Transfus. Clin. Biol. – 1997. – V. 4. – Р. 99–114.

145.Daniels G.L., Green C. Expression of red cell surface antigens during erythropoiesis // Vox Sang.–2000. – V. 78(Suppl.1).–Р. 149–153.

146.Daniels G.L., Hadley A.G., Green C.A. Fetal anaemia due to anti-K may result from immune destruction of early erythroid progenitors [Abstract] // Transfus. Med. – 1999. – V. 9 (Suppl.). – Р. 16.

147.Daniels G.L., Moulds J.J.,AnsteeD.J. et al. ISBTworking party on terminology for red cell surface antigens // Vox Sang. – 1993. – V. 65. – Р.77–80.

148.Daniels G.L., PettyA.C., Reid M. et al. Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system // Transfusion. – 1994. – V. 34. – Р. 818–820.

149.DanielsG.L.,ShawM.A.,JudsonP.A.etal.AfamilydemonstratinginheritanceoftheLeach phenotype: a Gerbich-negative phenotype associated with elliptocytosis // Vox Sang. – 1986. – V. 50. – Р. 117–121.

150.Daniels G.L., Weinauer F., Stone C. et al.Acombination of effects of rare genotypes at the XK and KELblood group loci results in absence of Kell system antigens from the red blood cells // Blood. – 1996. – V. 88. – P. 4045–4050.

151.Darnborough J., Dunsford I. Неопубликованное сообщение, 1959. Цит. по Race R. R., Sanger R. Blood Groups in Man. – 6-th ed. –Oxford: BSP, 1975. – Р. 303.

152.De Saint-Basile G., Bohler M.C., Fischer A. et al. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype // Hum. Genet. – 1988. – V. 80. – Р. 85–89.

153.DerringtonM.M.,SoothillJ.F.Animmunochemicalstudyoftheproteinsoftheamnioticfluid and of maternal and foetal serum // J. Obstet. Gynaec. Brit. Cwlth. – 1961. –V. 68. – Р. 755.

154.Dichupa P.J.,Anderson C., Chown B.Afurther search for hypothetic K pof the Kell-system

//Vox Sang. – 1969. – V. 17. – Р. 1–4.

155.Dinning G., Doughty R.W., Collins A.K.Afurther example of IgM anti-K2 (Cellano) // Vox Sang. – 1985. – V. 48. – Р. 317–318.

156.Doelman C.J., Westermann W.E., van Voorst tot Voorst E., Miedema K. An anti-K apparently inducedbyEnterococcusfaecalisina30-year-oldman//Transfusion.–1992.–V.32.–Р.790.

157.DonovanL..,TrippK.L.,ZuckermanJ.E.,KonugresA.A.Hemolyticdiseaseofthenewborn due to anti-Js a // Transfusion. – 1973. – V. 13. – Р. 153.

158.Dotti M. T., Battisti C., Malandrini A. et al. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene // Mot Disord. – 2000. – V. 15. – Р. 1282–1285.

434

159.Eby C.S., Cowan J.L., Ramos R.R., Chaplin H. In-vivo and in-vitro studies of anti-Kp b allo-antibody [Abstract] // Joint Congr. Int. Soc. Blood. Transfus. and Amer. Assoc. Blood Banks. – 1990. – P. 156.

160.Eicher C., Kirkley K., Porter M., Kao Y. A new low frequency antigen in the Kell system: K24 // Transfusion. – 1985. – V. 27. – P. 36–40.

161.El Nemer W., Colin Y., Collec E. et al. Analysis of deletions in three McLeod patients: exclusionoftheXSlocusfromtheXp21.1-Xp21.2region//Eur.J.Immunogenet.–2000.–

V.27. – Р. 29–33.

162.Eveland D. Autoanti-Js b enhanced by polyethylene glycol [Abstract] // Joint. Congr. Int. Soc. BloodTransfus.andAmer.Assoc.BloodBanks,1990.–P.156.

163.FikrigS.M.,PhillippJ.C.D.,SmithwickE.M.etal.ChronicgranulomatousdiseaseandMcLeod syndromeinaBlackchild//Pediatrics.–1980. – V. 66.– P. 403–404.

164.Ford D.S., Knight A.E., Smith F. A further example of Kp a / K° exhibiting depression of some Kellgroupantigens//VoxSang.–1977. – V. 32.– P. 220–223.

165.Francke U., Ochs H.D., de Martinville B. et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome // Amer. J. Hum. Genet. – 1985. –

V.37. – P. 250–267.

166.Frank S., Schmidt R.P., Baugh M. Three new antibodies to high-incidence antigenic determinants (anti-El, anti-Dp, and anti-So) // Transfusion. – 1970. – V. 10. – P. 254–257.

167.Frey D., Machler M., Seger R. et al. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus // Blood. – 1988. –

V.71. – P. 252–255.

168.Furuhjelm U., Nevanlinna H.R., Nurkka R. et al. Evidence that the antigen Ul a is controlled from the Kell complex locus // Vox Sang. – 1969. – V. 16. – P. 496–499.

169.Furuhjelm U., Nevanlinna H.R., Nurkka R. et al. The blood group antigen Ul a (Karhula) // Vox Sang. – 1968. – V. 15. – P. 118–124.

170.Galey W. R., Evan A. P., Van Nice P. S. et al. Morphology and physiology of the McLeod erythrocyte. I. Scanning electron microscopy and electrolyte and water transport properties // Vox Sang. – 1978. – V. 34. – P. 152–161.

171.Garratty G., Sattler M.S., Petz L.D., Flannery E.P. Immune hemolytic anemia associated with anti-Kell and a carrier state for chronic granulomatous disease // Rev. Franc. Transfus. Immunohemat. – 1979. – V. 22. – P. 529–549.

172.Garretta M., Gener J., Muller A. Analyse de 280000 determinations du facteur Kell sur les equipements Groupamatic // Rev. Franc. Transfus. Immunohemat. – 1978. – V. 2. –

P.379–386.

173.Gavin J., Daniels G.L., Yamaguchi H. et al. The red cell antigen once called Levay is the antigen Kp c of the Kell system // Vox Sang. – 1979. – V. 36. – P. 31–33.

174.Giblett E.R. A critique of the thoretical hazard of inter vs. intra-racial transfusion // Transfusion. – 1961. – V. 1. – P. 233–238.

175.Giblett E.R. Js, a ‘new’blood group antigen found in Negroes // Nature. – 1958. – V. 181. –

P.1221–1222.

176.GiblettE.R.,ChaseJ.Js a a‘new’redcellantigenfoundinNegroes;evidenceforaneleventh blood group system // Brit. J. Haemat. – 1959. – V. 5. – P. 319–326.

177.Giblett E.R., Klebanoff S. J., Pincus S.H. et al. Kell phenotypes in chronic granulomatous disease: a potential transfusion hazard // Lancet. – 1971. – i. – P. 1235–1236.

178.Glaubensklee C.S., Evan A.P., Galey W.R. Structural and biochemical analysis of the McLeod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis // Vox Sang. – 1982. – V. 42. – P. 262–271.

435

179.Goossens D., Champomier F., Rouger P., Salmon C. Human monoclonal antibodies against bloodgroupantigens:preparationofaseriesofstableEBVimmortalizedBclonesproducing high levels of antibody of different isotypes and specificities // J. Immunol. Methods. – 1987. – V. 101. – P. 193–200.

180.Gordon M.C., Kennedy M.S., O’Shaughnessy R.W., Waheed A. Severe hemolytic disease of the newborn due to anti-Js b // Vox Sang. – 1995. – V. 69. – P. 140–141.

181.GorlinJ.B.,KellyL.AlloimmunisationviaprevioustransfusionplacesfemaleKp b-negative recipients at risk for having children with clinically significant hemolytic disease of the newborn // Vox Sang. – 1994. – V. 66. – P. 46–8.

182.Grant S.R., Kilby M.D., Meer L. et al. The outcome of pregnancy in Kell alloimmunisation // Brit.J.Obstet.Gynec.–2000.–V.107.–P.481–485.

183.Greenwalt T.J., Walker R.H., Argall C.I. et al. Js b of the Sutter blood group system // Proc. 9-th Congr. int. Soc. Blood Transf. – Mexico, 1962. – P. 235–237.

184.Grove-Rasmussen M., Huggins C.E. Selected types of frozen blood for patients with multiple blood group antibodies // Transfusion. – 1973. – V. 13. – P. 124.

185.Guevin R.M., Taliano V., Waldmann O. The Cote serum (anti-K11), an antibody defining a new in variant the Kell system // Vox Sang. – 1976. – V. 31 (Suppl. 1). – P. 96–100.

186.Guevin R.M., Taliario V., Waldmann O. The Cote serum, an antibody defining a new variant in theKellsystem//Amer.Ass.BloodBanks,Program:24-thAnnualMeeting,1971.–P.100.

187.Hamilton H.B., Nakahara Y. The rare Kell blood group phenotype K° in a Japanese family

//Vox Sang. – 1971. – V. 20. – P. 24–28.

188.Hanaoka N., Yoshida K., Nakamura A. et al. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family // J. Neurol. Sci. – 1999. –V. 165. – P. 6–9.

189.Hardie R.J., Pullon H.W. H., Harding A.E. et al. Neuroacanthocytosis: a clinical, haematological and pathological study of 19 cases // Brain. – 1991. – V. 114. – P. 13–49.

190.Hardman J.T., Beck M.L. Hemagglutination in capillaries: correlation with blood group specificity and IgG subclass // Transfusion. – 1981. – V. 21. – P. 343–346.

191.HardyJ.,NapierJ.A.RedcellantibodiesdetectedinantenataltestsonRhesuspositivewoman in south and midWales 1948–1978 // Brit. J. Obstet. Gynaec. – 1981. –V. 88. – P. 91–100.

192.Hare V., Wilson M.J., Wilkinson S., Issitt P.D. A Kell system antibody with highly unusual characteristics [Abstract] // Transfusion. – 1981. – V. 21. – P. 613.

193.Harrison J. The ‘naturally occurring’anti-E // Vox Sang. – 1970. – V. 19. – P. 123.

194.Hawley W.C., Blanda E., Kennedy M.S. (abstract) // Transfusion. – 1975. – V. 15. – P. 521.

195.Heisto H., Guevin R. M., Taliano V. et al. Three further antigen-antibody specificities associated with the Kell blood group system // Vox Sang. – 1973. – V. 24. – P. 179–180.

196.Hessner M.J., McFarland J G., Endean D.J. Genotyping of KEL1 and KEL2 of the human Kell gene blood group system by the polymerase chain reaction with sequence-specific primers //Transfusion. – 1996. –V. 36. – P. 495–499.

197.Heyworth P.G., Curnutte J.T., Rae J. et al. Hematologically important mutations: X-linked chronic granulomatous disease (second update) // Blood Cells Mol. Dis. – 2001. – V. 27. – P. 16–26.

198.Ho M., Chelly J., Carter N. et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein // Cell. – 1994. – V. 77. – P. 869–880.

199.HoM.E.,ChalmersR.M.,DavisM.B.etal.AnovelpointmutationintheMcLeodsyndrome gene in neuroacanthocytosis //Ann. Neurol. – 1996. – V. 39. – P. 672–675.

200.Ho M.F., Monaco A.P., Blonden L.A. J. et al. Fine mapping of the McLeod locus (XK) to a 150–380 kb region in Xp21 //Amer. J. Hum. Genet. – 1992. – V. 50. – P. 317–330.

201.Hughes-Jones N.C., Gardner B.The Kell system studied with radioactively-labelled anti-K

//Vox Sang. – 1971. – V. 21. – P. 154–158.

202.Inglis G., Fraser R.H., McTaggart S. et al. Monoclonal antibodies to high incidence Kell epitopes: characterization and application in automated screening of donor samples // Transfus. Med. – 1994. – V. 4. – P. 209–212.

436

203.Issitt P.D. On the incidence of second antibody populations in the sera of women who have developed anti-Rh antibodies // Transfusion. – 1965. – V. 5. – P. 355.

204.Issitt P.D., Anstee D.J. Applied Blood Group Serology. – 4-th ed. – Durham, NC, USA: Montgomery Sc. Publ., 1998. – P. 609–653.

205.Issitt P.D., Combs M.R., Bredenhoeft S.J. et al. Lack of clinical significance of «enzymeonly» red cell alloantibodies // Transfusion. – 1993. – V. 33. – P. 284–293.

206.Issitt P.D., Combs M.R., Bumgarner D.J. et al. Studies of antibodies in the sera of patients who have made red cell autoantibodies // Transfusion. – 1996. – V. 36. – P. 481–486.

207.Issitt P.D., McKeever B.G., Moore V.K., Wilkinson S.L. Three examples of Rh-positive, good responders to blood group antigens // Transfusion. – 1973. – V. 13. – P. 316.

208.Issitt P.D., PavoneB.G. Criticalre-examinationof thespecificityof auto-anti-Rhantibodies in patients with a positive direct antiglobulin test // Brit. J. Haemat. – 1978. –V. 38. – P. 63.

209.Ito K., Mukumoto Y., Konishi H. An example of ‘naturally occurring’ anti-Js a (K6) in a Japanese female // Vox Sang. – 1979. – V. 37. – P. 350–351.

210.Jaber A., Blanchard D., Goossens D. et al. Characterization of blood group Kell (K1) antigenwithahumanmonoclonalantibody­//Blood.–1989.–V.73.–N6.–P.1597–1602.

211.Jaber A., Loirat M., Willem C. et al. Characterization of murine monoclonal antibodies directed against the Kell blood group glycoprotein // Brit. J. Haemat. – 1991. – V. 79. –

P.311–315.

212.Jarkowski T.L., Hinshaw C.P., Beattie K.M., Silberberg B. Another example of anti-Js a // Transfusion. – 1962. – V. 2. – P. 423.

213.Jones J., Reid M.E., Oyen R. et al. A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens // Vox Sang. – 1995. – V. 69. – P. 53–60.

214.Jongeneel C.V., Bouvier J., Bairoch A. A unique signature identifies a family of zincdependent metallopeptidases // FEBS Lett. – 1989. – V. 242. – P. 211–214.

215.Jongerius J.M., Daniels G.L., Overbeeke M.A.M. et al.Anew low-incidence antigen in the Kell blood group system VLAN (KEL25) // Vox Sang. – 1996. – V. 71. – P. 43–47.

216.Judd W.J. Methods in Immunohematology // Montgomery Scientific Publications. – 2-nd. – 1994. – 476 p.

217.Judd W.J., Walter W J., Steiner E.A. Clinical and laboratory­ findings on two patients with naturally occurring anti-Kell agglutinins // Transfusion. – 1981. – V. 21. – P. 184–188.

218.Judson P.A., Anstee D.J. Comparative effect of trypsin and chymotrypsin on blood group antigens // Med. Lab. Sci. – 1977. – V. 34. – P. 1–6.

219.Jung H.H., Hergersberg M., Kneifel S. et al. McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings // Ann. Neurol. – 2001. – V. 49. – P. 384–392.

220.KaitaH.,LewisM.,ChownB.,CardE.AfurtherexampleoftheKellbloodgroupphenotype K −, k −, Kp(a −b −) // Nature. – 1959. – V. 183. – P. 1586.

221.Kanel G.C., Davis I., Bowman J.E. ‘Naturally-occurring’anti-K1: possible association with mycobacterium infection­ // Transfusion. – 1978. – V. 18. – N 4. – P. 472–473.

222.Kawakami T., Takiyami Y., Sakoe K. et al. A case of McLeod syndrome with unusually severe myopathy // J. Neuro. Sci. – 1999. – V. 166. – P. 36–39.

223.Kelley C.M., Karwal M.W., Schlueter A.J., Olson J.D. Outcome of transfusion of K:11 erythrocytes in a patient with anti-K11 antibody // Vox Sang. – 1998 – V. 74. – P. 205–208.

224.Khamlichi S., Bailly P., Blanchard D. et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients // Eur. J. Biochem. – 1995. –

V.228. – P. 931–934.

225.Kikuchi M., Endo N., Seno T. et al.AJapanese family with two Kp(a −b −c + ) members, pre­ sumed genotype Kp c / K° // Transfusion.. – 1983. – V. 23. – P. 254–255.

226.Kline W.E., Sullivan C.M., Bowman R.J.Arare example of weakened expression of the Kell (K1) antigen // Vox Sang. – 1984. – V. 47. – P. 170–173.

437

227.KlugeA., Jungfer H.Anti-K2 (Cellano) blood group antibodies: typing as IgG and IgAwith a review of their clinical significance // Blut. – 1970. – V. 21. – P. 357–365.

228.Kohan A.I., Reybaud J.F., Salamone H.J. et al. Management of a severe transfusional problem in a patient with alloantibody to Kp b (K4) // Vox Sang. – 1990. – V. 59. –

P.216–217.

229.Kornstad L., Heistö H. The frequency of formation of Kell antibodies in recipients of Kellpositive blood // Proc. 6-th Congr. Europ. Soc. Haemat. – Copenhagen, 1957. – P. 754.

230.KuypersF.A.,vanLinde-SibeniusTripM.,RoelofsenB.etal.Thephospholipidorganisation in the membranes of McLeod and Leach phenotype erythrocytes // FEBS Lett. – 1985. –

V.184. – P. 20–44.

231.Lee S. Molecular basis of Kell blood group phenotypes // Vox Sang. – 1997. – V. 73. –

P.1–11 and Vox Sang. – 1998. – V. 74. – P. 58.

232.Lee S., Bennett P.R., Overton T. et al. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2 //Amer. J. Obstet. Gynecol. – 1996. – V. 175. – P. 455–459.

233.Lee S., Lin M., Mele A. et al. Proteolytic processing of big endothelin–3 by the Kell blood group protein // Blood.– 1999. – V. 94. – P. 1440–1450.

234.Lee S., Naime D., Reid M., Redman C. The KEL24 and KEL24 alleles of the Kell blood group system // Transfusion. – 1997. – V. 37. – P.1035–1038.

235.Lee S., Reid M.E., Redman C.M. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system // Vox Sang.–2001.–V.81.–P.259–263.

236.Lee S., Russo D.C.W., Pu J. et al. The mouse Kell blood group gene (Kel): cDNA sequence, genomicorganization,expression,andenzymaticfunction//Immunogenetics.–2000.–V.52.–

P.53–62.

237.Lee S., Russo D.C., Reid M., Redman C. Mutations that diminish expression of Kell

surface protein and lead to the Kmod RBC phenotype // Transfusion. – 2003. – V. 43. – N 8. – P. 1121–1225.

238.Lee S., Russo D.C.W., Reiner A.P. et al. Molecular defects underlying the Kell null phenotype // J. Biol. Chem. – 2001. – V. 276. – P. 27281–2729.

239.Lee S., Wu X., Reid M. et al. Molecular basis of the Kell (Kl) phenotype // Blood. – 1995. –

V.85. – P. 912–916.

240.Lee S., Wu X., Reid M., Redman C. Molecular basis of the K:6,–7 [Js(a +b −)] phenotype in the Kell blood groups system // Transfusion. – 1995. – V. 35. – P. 822–825.

241.LeeS.,WuX.,SonS.etal.PointmutationscharacterizeKEL10,theKEL3,KEL4,andKEL21 alleles, and the KEL17 and KEL11 alleles //Transfusion. – 1996. –V. 36. – P. 490–494.

242.LeeS.,ZambasE.D.,GreenE.D.,RedmanC.Organizationofthegeneencodingthehuman Kell blood group protein // Blood. – 1995. – V. 85. – P. 1364–1370.

243.Lee S., Zambas E.D., Marsh W.L., Redman C.M. Molecular cloning and primary structure of Kell blood group protein // Proc. Nat.Acad. Sci. USA. – 1991. – V. 88. – P. 6353–6357.

244.Lee S., Zambas E.D., Marsh W.L., Redman C.M. The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells // Blood. – 1993. –

V.81. – P. 2804–2809.

245.Leggat H.M., Gibson J.M., Barren S.L., Reid M.M.Anti-Kell in pregnancy // Brit. J. Obstet. Gynec. – 1991. – V. 98. – P. 162–165.

246.Levene C., Rudolphson Y., Shechter Y. A second case of hemolytic disease of the newborn due to anti-Js a // Transfusion. – 1980. – V. 20. – P. 714–715.

247.Levene C., Sela R., DaCosta Y., Manny N. Clinical significant of anti-K22 [Abstract]. 20th Congr // Int. Soc. Blood. Transfus. – 1988. – P. 295.

248.Levine P. The influence of the ABO system on hemolytic disease // Hum. Biol. – 1958. –

V.30. – P. 14.

249.Lewine P., Backer M., Wigod M., Ponder R. A new human hereditary blood property (Cellano) present in 99,8 % of all bloods // Science. – 1949. – V. 109. – P. 464–467.

438

250.Lewis M, Chown B, Kaita H. Inheritance of blood group antigens in a largely Eskimo population sample //Amer. J. Hum. Gene. – 1963. – V. 15. – P. 203–208.

251.Lewis M., Kaita H., Chown B. The inheritance of the Kell blood groups in a Caucasian population sample // Vox Sang. – 1969. – V. 17. – P. 221–223.

252.Lewis M., Kaita H., Duncan D., Chown B. Failure to find hypothetic K a (KKp a) of the Kell blood group system // Vox Sang. – 1960. – V. 5. – P. 565–567.

253.Lombardo J.M., Britton S.J., Hannon G., Terry D. Kо in a sister and brother, a family study

//AbstractsAABB and ISH Meeting. –Washington, 1972. – P. 59.

254.Longster G.H., Major K.E. Anti-K (K1) in ascitic fiuid // Vox Sang. – 1975. – V. 28. –

P.253.

255.Lowe R.F., MusengeziA.T, Moores P. Severe hemolytic disease of the newborn associated with anti-Js b // Transfusion. – 1978. – V. 18. – P. 466–468.

256.Manny N., Levene C., Harel N. et al. The second example of anti-K22 and a family genetically informative for and K22 // Vox Sang. – 1985. – V. 49. – P. 135–137.

257.Manny N., Levene C., Sela R. et al.Autoimmunity and the Kell blood groups: auto-anti-Kp b in a Kp(a +b −) patient // Vox Sang. – 1983. – V. 45. – P. 252–256.

258.Marsh W.L. Letter // Vox Sang. – 1979. – V. 36. – P. 375–376.

259.Marsh W.L., Marsh N.J., MooreA. et al. Elevated serum creatine phosphokinase in subjects with MacLeod syndrome // Vox Sang. – 1981. – V. 40. – P. 403–411.

260.Marsh W.L., DiNapoli J., Qyen R. et al. Delayed hemolytic transfusion reaction caused by the second example of anti-K19 // Transfusion. – 1979. – V. 19. – P. 604–608.

261.Marsh W.L., DiNapoli J., Qyen R.Auto-immune hemolytic anemia caused by anti-K13 // Vox Sang.–1979.–V.36.–P.174–178.

262.Marsh W.L., Jensen L., Oyen R. et al. Anti-K13 and the K:-13 phenotype: a blood-group variant related to the Kell system // Vox Sang. – 1974. – V. 26. – P. 34–40.

263.Marsh W.L., Mueller K.A., Johnson C.L. Use of AET-treated cells in the investigation of Kell related autoimmunity [Abstract] // Transfusion. – 1982. – V. 22. – P. 419.

264.Marsh W.L., Nichols M.E., Qyen R. et al. Naturally occurring anti-Kell stimulated by E. coli enterocolitis in a 20-day-old child // Transfusion. – 1978. – V. 18. – P. 149–154.

265.Marsh W.L., Qyen R., Alicea E. et al. Autoimmune hemolytic anemia and the Kell blood groups //Amer. J. Hematol. – 1979. – V. 7. – P. 155–162.

266.Marsh W.L., Qyen R., Nichols M.E. Kx antigen, the McLeod phenotype, and chronic granulomatous disease: further studies // Vox Sang. – 1976. – V. 31. – P. 356–362.

267.Marsh W.L., Qyen R., Nichols M.E.,Allen F.H. Chronic granulomatous disease and the Kell blood groups // Brit. J. Haemat. – 1975. – V. 29. – P. 247–262.

268.Marsh W.L., Redman C.M. Recent developments in the Kell blood group system // Transfusion Med. Rev. – 1987. – V. 1. – P. 4–20.

269.Marsh W.L., Redman C.M. The Kell blood group system: a review // Transfusion. – 1990. –

V.30. – P. 158–167.

270.Marsh W.L., Redman C.M., Kessler L.A. et al. K23: a low-incidence antigen in the Kell blood group system identified by biochemical characterization // Transfusion. – 1987. –

V.27. – P. 36–40.

271.Marsh W.L., Schnipper E.F., Johnson C.L. et al.An individual with McLeod syndrome and the Kell blood group antigen K (K1) // Transfusion. – 1983. – V. 23. – P. 336–338.

272.Marsh W.L., Stroup M., Macilroy M. et al. A new antibody, anti-K12, associated with the Kell blood group system // Vox Sang. – 1973. – V. 24. – P. 200–205.

273.Marsh W.L., Taswell M.F., Oyen R. et al. Kx antigen of the Kell system and its relationship to chronic granulomatous disease. Evidence that the Kx gene is X-linked // Transfusion. – 1975. – V. 15. – N 3. – P. 527.

274.Mastroberardino L., Spindler B., Pfeiffer R. et al.Amino-acid transport by heterodimers of 4F2hc / CD98andmembersofthepermeasefamily//Nature.–1998.–V.395.–P.288–291.

439

275.MazzaraR.,LozanoM.,SalmeronJ.M.etal.TransfusionofincompatibleRBCstoapatient with alloanti-Kp b // Transfusion. – 2001. – V. 41. – P. 611–614.

276.McDowell M.A., Mann J.M., Milakovic K. Kell-like antibody in a Kell positive patient [Abstract] // Transfusion. – 1978. –V. 18. – P. 389.

277.McGinniss M.H., Dean A. Expression of red cell antigens by K562 human leukemia cells before and after induction of hemoglobin synthesis by hemin // Transfusion. – 1985. –

V.25. – P. 105–109.

278.McGinniss M.H., MacLowry J.D., Holland P.V. Acquisition of K1-like antigen during terminal sepsis // Transfusion. – 1984. – V. 24. – P. 28–30.

279.McKennaD.S.,NagarajaH.N.,O’ShaughnessyR.Managementofpregnanciescomplicated by anti-Kell isoimmunization // Obstet. Gynecol. – 1999. – V. 93. – P. 667–673.

280.McNeil C., Newman M. Неопубликованное сообщение, 1966. Цит. по Race R. R., Sanger

R.Blood Groups in Man. – 6-th ed. –Oxford: BSP, 1975. – P. 303.

281.Merry A.H., Thomson E.E., Anstee D.J., Stratton F. The quantification of erythrocyte antigen sites with monoclonal antibodies // Immunology. – 1984. – V. 51. – P.793–800.

282.Merry A.H., Thomson E.E., Lagar J. et al. Quantitation of antibody binding to erythrocytes in LISS // Vox Sang. – 1984. – V. 47. – P. 125–132.

283.MifsudN.A.,HaddadA.P.,SparrowR.L.,CondonJ.A.Useofthepolymerasechainreactionsequence specific oligonucleotide technique for the detection of the K1 / K2 polymorphism of the Kell blood groups system // Blood. – 1997. – V. 89. – P. 4662–4663.

284.Mollison P.L., Engelfriet C.P., Contreras M. Blood Transfusion in Clinical Medicine. – 10-th ed. – Oxford: BSP, 1997. – 1033 p.

285.Molthan L., Strohm P.L. Hemolytic transfusion reaction due to anti-Kell undetectable in low- ionicstrengthsolutions//Amer.J.Clin.Path.–1981.–V.75.–P.629–631.

286.Moore S.B., Taswell H.F., Pineda A.A. Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test //Amer. J. Clin. Path. – 1980. – V. 74. –

P.94–97.

287.MorganP.,BossomE.L.‘Naturallyoccurring’anti-Kell(K1):twoexamples//Transfusion.– 1963. – V. 3. – P. 397–398.

288.Morton N.E., Krieger H., Steinberg A. G., Rosenfield R.E. Genetic evidence confirming the localization of Sutter in the Kell blood-group system // Vox Sang. – 1965. –V. 10. –

P.608–613.

289.Moulds J.J., Moulds M.K. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide // Transfusion. – 1983. – V. 23. – P. 274–275.

290.MourantA.E.,KopecA.C.,Domaniewska-SobczakK.TheDistributionoftheHumanBlood Groups and Other Polymorphisms, 2-nd ed. – London: Oxford University Press, 1976.

291.Mukumoto Y., Konishi H., Ito K. et al.An example of naturally occurring anti-Kell (K1) in a Japanese male // Vox Sang. – 1978. – V. 35. – P. 275–276.

292.Muller A., Andre-Liardet J., Garretta M. et al. Observations sur un anticorps rare. 1’antiGerbich // Rev Franc Transfus. –1973. – V. 16. – P. 251–257.

293.Mullis N. C., Harris D. F., Roberts C. et al. Intravascular hemolysis caused by anti-K2 [Abstract] // Transfusion. – 1999. – V. 39 (Suppl.). – P. 475.

294.Murphy M.T., Fraser R.H., Goddard J.P. Development of a PCR-based diagnostic assay for the determination of KEL genotype in donor blood samples // Transfus. Med. – 1996. –V. 6. – P. 133–137.

295.Murphy M.T., Morrison N., Miles J. S. et al. Regional chromosome assigment of the Kell blood group locus (KEL) to chromosome 7q33-q35 by fluorescence in situ hybridization: evidence for the polypeptide nature of antigenic variation // Hum. Genet. – 1993. – V. 91. –

P.585–588.

440